Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07827690

Effects of Transcutaneous Vagus Nerve Stimulation on Pain and Brain Activity in Healthy Adults

The goal of this clinical trial is to learn whether stimulating a nerve in the neck changes how much pain people feel. It also looks at whether this stimulation changes brain activity. The study is being done in healthy adults ages 18 to 70.

The nerve being studied is called the vagus nerve. It runs through the neck and connects to parts of the brain that handle pain. In this study, the nerve is stimulated from outside the body using a small device placed on the skin. There is no surgery, and nothing is implanted.

The main questions it aims to answer are: (1) Does stimulating the vagus nerve lower the pain people feel during a cold water test? (2) Does stimulating the vagus nerve change the electrical activity in the brain?

Researchers will compare pain ratings and brain activity under three conditions in the same person: no stimulation, real stimulation over the vagus nerve, and sham stimulation placed nearby on the neck. Sham stimulation feels similar but is not aimed at the nerve.

Participants will: (1) Come to one visit that lasts about 90 minutes, with no follow-up visits, (2) Wear a cap that records the brain's natural electrical signals for the whole visit, (3) Place both hands in cold water, about 39 degrees Fahrenheit, up to three times for up to 2 minutes each time, (4) Rate their pain after each cold water test, (5) Wear a stimulation device on the neck during two of the three cold water tests, (6) Not be told which of those two is the real stimulation until the visit is over.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Acute Pain Healthy Adult Participants Neurologic Manifestations Pain Pain Perception Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

IU Health Neuroscience Center

Indianapolis, Indiana, 46202, United States

Location contact

Department of Neurological Surgery

CONTACT

[email protected]

317-963-1300

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 to 70 years
  • Healthy, defined as having no history of chronic medical, neurological, or psychiatric conditions
  • Not currently experiencing acute illness or chronic pain
  • Not currently taking medications that influence the nervous system or pain sensitivity
  • Willing and able to provide written informed consent in English

Exclusion criteria

  • History of vagal or vasovagal symptoms
  • Respiratory distress
  • Cardiac arrhythmia
  • Sleep apnea
  • Pregnancy
  • Substance abuse
  • Primary psychiatric disorder
  • Prior vagus nerve stimulation or any implanted medical device
  • Significant acute or chronic neurologic illness that, in the judgment of the Principal Investigator, could compromise participant safety, limit the ability to complete the study, or compromise the objectives of the study

Treatment and study plan

Active transcutaneous vagus nerve stimulation

Device

Stimulation applied over the cervical branch of the vagus nerve, anterior to the sternocleidomastoid along the carotid sheath. Pulse width 200 microseconds, frequency 30 Hz, rectangular monophasic waveform, intensity titrated between 17.8 and 39.5 volts to a mild tingling sensation below the threshold of discomfort. Stimulation is maintained for 20 minutes before the cold pressor test and continues throughout it.

Sham transcutaneous vagus nerve stimulation

Device

Identical device, parameters, and duration as the active condition, differing only in placement. The device is positioned slightly posterior on the neck, away from the cervical branch of the vagus nerve.

Cold pressor test

Other

Immersion of both hands up to the wrist in water maintained at 4 degrees Celsius with ice for up to two minutes or as long as tolerated. Performed three times per participant: once with no stimulation, once during active stimulation, and once during sham stimulation.

Primary outcomes

  1. Pain intensity measured by the Numerical Pain Rating Scale

    Time frame: Immediately after each of the three cold pressor tests during a single visit, approximately 90 minutes.

    Participant-reported pain intensity on an 11-point scale from 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. Higher scores indicate greater pain. Rated immediately after each cold pressor test.

  2. Pain intensity measured by the Visual Analogue Scale

    Time frame: Immediately after each of the three cold pressor tests during a single visit, approximately 90 minutes.

    Participant-reported pain intensity is marked on a 100 mm line anchored at 0 mm for no pain and 100 mm for the worst imaginable pain. The distance in millimeters from the left anchor is recorded as the score. Higher scores indicate greater pain. Rated immediately after each cold pressor test.

  3. Pain threshold during cold pressor test

    Time frame: During each of the three cold pressor tests within a single visit, approximately 90 minutes.

    Time in seconds from hand immersion to the participant's first verbalized sensation of pain, recorded separately for each hand.

Secondary outcomes

  1. Change in EEG spectral power

    Time frame: Continuously throughout a single visit, approximately 90 minutes.

    Change in spectral power within canonical frequency bands (delta 1 to 4 Hz, theta 4 to 8 Hz, alpha 8 to 12 Hz, beta 13 to 30 Hz, gamma above 30 Hz), measured by continuous 16-channel electroencephalography, compared across resting baseline, stimulation without noxious stimulus, and stimulation during cold pressor test.

  2. Change in EEG functional connectivity

    Time frame: Continuously throughout a single visit, approximately 90 minutes.

    Change in functional connectivity between brain regions, derived from continuous 16-channel electroencephalography. Phase locking values are computed for each pair of EEG channels within canonical frequency bands, and connectivity metrics are derived from those values. Coherence is assessed in the frequency domain. Analyses are restricted to predefined, theory-driven regions and frequency bands. Compared across resting baseline, stimulation without noxious stimulus, and stimulation during the cold pressor test.

Study contacts

Contact information is provided by the study sponsor or research team.

Caliel Hines

CONTACT

[email protected]

317-963-7010

Marissa Lowe

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

David A. Purger

Other

Collaborators

  • Indiana University Health
  • Indiana University Health Methodist Hospital
  • Purdue University

Registry information

Official study title

The Effects of Transcutaneous Vagus Nerve Stimulation (tVNS) on Acute Pain Perception and Brain Activity in Healthy Adults

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 18, 2026
Registry last updated
Sep 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.